Zobrazeno 1 - 10
of 19
pro vyhledávání: '"Yuki Kugiyama"'
Autor:
Shigemune Bekki, Satoru Hashimoto, Kazumi Yamasaki, Atsumasa Komori, Seigo Abiru, Shinya Nagaoka, Akira Saeki, Tomoyuki Suehiro, Yuki Kugiyama, Asami Beppu, Tamotsu Kuroki, Minoru Nakamura, Masahiro Ito, Hiroshi Yatsuhashi
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0241002 (2020)
BackgroundWe examined serum kynurenine levels in patients with chronic hepatitis C virus infection, and the relationship between serum kynurenine and prognosis in patients with hepatocellular carcinoma (HCC) and chronic hepatitis C.MethodsWe retrospe
Externí odkaz:
https://doaj.org/article/3fbc73351284471c86692e32d7b22e67
Autor:
Satoru Hashimoto, Hiroshi Yatsuhashi, Seigo Abiru, Kazumi Yamasaki, Atsumasa Komori, Shinya Nagaoka, Akira Saeki, Shinjiro Uchida, Shigemune Bekki, Yuki Kugiyama, Kazuyoshi Nagata, Minoru Nakamura, Kiyoshi Migita, Kazuhiko Nakao
Publikováno v:
PLoS ONE, Vol 11, Iss 9, p e0163644 (2016)
BACKGROUND & AIM:We performed lipid analyses at the early period of therapy in patients with chronic hepatitis C who underwent interferon (IFN)-free direct-acting antiviral (DAA) treatment, and we attempted to identify the factors that contributed to
Externí odkaz:
https://doaj.org/article/0bb76bf0a682426faac4a251ccaa15b5
Autor:
Ryu Sasaki, Kazumi Yamasaki, Seigo Abiru, Atsumasa Komori, Shinya Nagaoka, Akira Saeki, Satoru Hashimoto, Shigemune Bekki, Yuki Kugiyama, Atsushi Kuno, Masaaki Korenaga, Akira Togayachi, Makoto Ocho, Masashi Mizokami, Hisashi Narimatsu, Tatsuki Ichikawa, Kazuhiko Nakao, Hiroshi Yatsuhashi
Publikováno v:
PLoS ONE, Vol 10, Iss 6, p e0129053 (2015)
Measurement of Wisteria floribunda agglutinin-positive human Mac-2 binding protein (WFA+-M2BP) in serum was recently shown to be a noninvasive method to assess liver fibrosis. The aim of this study was to evaluate the utility of serum WFA+-M2BP value
Externí odkaz:
https://doaj.org/article/5947d62c64574bec87294706c7c408ae
Autor:
Atsumasa Komori, Satoru Hashimoto, Akira Saeki, Asami Beppu, Kazumi Yamasaki, Hiroshi Yatsuhashi, Tomoyuki Suehiro, Shinya Nagaoka, Yuki Kugiyama, Shigemune Bekki, Seigo Abiru
Publikováno v:
Kanzo. 61:18-23
Autor:
Satoshi Matsuo, Satsuki Hashimoto, Ryu Sasaki, Toshihisa Matsuzaki, Yasuhide Motoyoshi, Noboru Kinoshita, Kazuo Ohba, Satoshi Miuma, Hidetaka Shibata, Hiroshi Yatsuhashi, Kazuhiko Nakao, Susumu Eguchi, Hisamitsu Miyaaki, Yuji Kato, Yuki Kugiyama, Masafumi Haraguchi, Masaaki Hidaka, Masanori Fukushima, Masaya Shigeno, Shinichi Iwatsu
Publikováno v:
Anticancer research. 41(4)
Background The age of patients with advanced hepatocellular carcinoma (HCC) eligible for molecular-targeted drug treatment is increasing. We assessed liver function after lenvatinib administration according to age in patients with advanced HCC. Patie
Autor:
Kazumi Yamasaki, Satoru Hashimoto, Shinya Nagaoka, Asami Beppu, Tamotsu Kuroki, Seigo Abiru, Minoru Nakamura, Shigemune Bekki, Yuki Kugiyama, Atsumasa Komori, Hiroshi Yatsuhashi, Masahiro Ito, Akira Saeki, Tomoyuki Suehiro
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0241002 (2020)
PLoS ONE
PLoS ONE
BackgroundWe examined serum kynurenine levels in patients with chronic hepatitis C virus infection, and the relationship between serum kynurenine and prognosis in patients with hepatocellular carcinoma (HCC) and chronic hepatitis C.MethodsWe retrospe
Autor:
Ryu Sasaki, Kazuyoshi Nagata, Masanori Fukushima, Masafumi Haraguchi, Satoshi Miuma, Hisamitsu Miyaaki, Akihiko Soyama, Masaaki Hidaka, Susumu Eguchi, Masaya Shigeno, Mio Yamashima, Shinobu Yamamichi, Tatsuki Ichikawa, Yuki Kugiyama, Hiroshi Yatsuhashi, Kazuhiko Nakao
Publikováno v:
Cancers; Volume 14; Issue 3; Pages: 827
Cancers, Vol 14, Iss 827, p 827 (2022)
Cancers, Vol 14, Iss 827, p 827 (2022)
Background: Atezolizumab plus bevacizumab therapy has high response rates in patients with unresectable hepatocellular carcinoma (HCC). The hepatobiliary phase of gadoxetic acid-enhanced magnetic resonance imaging (EOB-MRI) has been reported to be us
Autor:
Shinya Nagaoka, Akira Saeki, Seigo Abiru, Satoru Hashimoto, Yuki Kugiyama, Asami Hori, Kazumi Yamasaki, Hiroshi Yatsuhashi, Atsumasa Komori, Tomoyuki Suehiro, Shigemune Bekki, Masahiro Itoh
Publikováno v:
Journal of Hepatology. 70:e397-e398
Autor:
Masakuni Tateyama, Akira Saeki, Hiroshi Yatsuhashi, Akira Togayachi, Kazumi Yamasaki, Yuri Miyazoe, Masaaki Korenaga, Atsushi Kuno, Makoto Ocho, Seigo Abiru, Atsumasa Komori, Hisashi Narimatsu, Ryu Sasaki, Shinya Nagaoka, Masashi Mizokami, Shigemune Bekki, Satoru Hashimoto, Yuki Kugiyama
Publikováno v:
Hepatology (Baltimore, Md.)
The Wisteria floribunda agglutinin-positive human Mac-2-binding protein (WFA+-M2BP) was recently shown to be a liver fibrosis glycobiomarker with a unique fibrosis-related glycoalteration. We evaluated the ability of WFA+-M2BP to predict the developm
Autor:
Kazumi Yamasaki, Shinya Nagaoka, Tamotsu Kuroki, Atsumasa Komori, Shigemune Bekki, Masahiro Ito, Kazuhiko Nakao, Seigo Abiru, Yasuhiko Nakao, Satoru Hashimoto, Akira Saeki, Yuki Kugiyama, Hiroshi Yatsuhashi
Publikováno v:
Journal of Hepatology. 68:854-855